Agouti signaling protein stimulates cell division in "viable yellow" (Avy/a) mouse liver

Experimental Biology and Medicine

Volumn 232, Issue 10, 2007, Pages 1326-1329

  Wolff, George L ^a,c   Stanley, J Steven ^a   Ferguson, Matthew E ^a   Simpson, Pippa M ^b   Ronis, Martin J J ^a   Badger, Thomas M ^a,b,d  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^c NONE   (United States)

^d U S DEPARTMENT OF AGRICULTURE   (United States)

Author keywords

Agouti signaling protein; Cell division; Pseudoagouti mice

Indexed keywords

AGOUTI PROTEIN; CELL NUCLEUS ANTIGEN;

ANIMAL EXPERIMENT; ARTICLE; CARCINOGENESIS; CELL DIVISION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; HOUSEKEEPING GENE; LIVER CELL; LIVER TUMOR; MITOSIS; MOUSE; NONHUMAN; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

AGOUTI SIGNALING PROTEIN; ANIMALS; CELL DIVISION; HEPATOCYTES; LIVER; MICE; MICE, MUTANT STRAINS; PROLIFERATING CELL NUCLEAR ANTIGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

AGOUTI; MUS;

EID: 35548946796     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.3181/0704-BC-95     Document Type: Article

References (21)

1. Duhl DMJ, Vrieling H, Miller KA, Wolff GL, Barsh GS. Neomorphic agouti mutations in obese yellow mice. Nat Genet 8:59-65, 1994.
2. w) reveals alternative forms of agouti transcripts. Genes Dev 8:481-490, 1994.
3. vy/A) (BALB/c x VY)F-1 hybrid mice by hyperglycemic peptides from human pituitary glands. Endocrinology 113:2097-2105, 1983.
4. 1 hybrid mice. Proc Soc Exp Biol Med 193:155-163, 1990.
5. Wolff GL, Roberts DW, Mountjoy KG. Physiological consequences of ectopic agouti gene expression: the yellow obese mouse syndrome. Physiol Genomics 1:151-163, 1999.
6. ya) and non-yellow (aa) mice in parabiosis. Genetics 48:1041-1058, 1963.
7. Huszar D, Lynch CA, Fairchild-Huntress V, Dunmore JH, Fang Q, Berkemeier LR, Gu W, Kesterson RA, Boston BA, Cone RD, Smith FJ, Campfield LA, Burn P, Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88:131-141, 1997.
8. vy/- mice: relation to adult hyperinsulinemia and obesity. Proc Soc Exp Biol Med 206:145-151, 1994.
9. Whittaker P, Dunkel VC, Bucci TJ, Kusewitt DF, Thurman JD, Warbritton A, Wolff GL. Genome-linked toxic responses to dietary iron overload. Toxicol Pathol 25:556-564, 1997.
10. Mountjoy KG, Wu CSJ, Dumont LM, Wild JM. Melanocortin-4 receptor messenger ribonucleic acid expression in cardiorespiratory, musculoskeletal, and integumentary systems. Endocrinology 144:5488-5496, 2003.
11. Mynatt RL, Stephens JM. Agouti regulates adipocyte transcription factors. Am J Physiol Cell Physiol 280:C954-C961, 2001.
12. Kuklin AI, Mynatt RL, Klebig ML, Kieffer LL, Wilkison WO, Woychik RP, Michaud EJ. Liver-specific expression of the agouti gene in transgenic mice promotes liver carcinogenesis in the absence of obesity and diabetes. Mol Cancer 3:17, 2004.
13. Furumura M, Sakai C, Potterf SB, Vieira WD, Barsh GS, Hearing V. Characterization of genes modulated during pheomelanogenesis using differential display. Proc Natl Acad Sci U S A 95:7374-7378, 1998.
14. Cooney CA, Dave AA, Wolff GL. Maternal methyl supplements in mice affect epigenetic variation and DNA methylation of offspring. J Nutr 132:2393S-2400S, 2002.
15. Westfall PH, Tobias RD, Rom D, Wolfinger RD, Hochberg Y. Multiple Comparisons and Multiple Tests Using the SAS System. Cary, North Carolina: SAS Institute, pp30, 1999.
16. Wolff GL, Medina D, Umholtz RL. Manifestation of hyperplastic alveolar nodules and mammary tumors in "viable yellow" and non-yellow mice. J Natl Cancer Inst 63:781-785, 1979.
17. 1 hybrid mice. J Toxicol Environ Health 10:131-142, 1982.
18. Wolff GL, Pitot HC. Variation of hepatic malic enzyme capacity with hepatoma susceptibility in mice of different genotypes. Cancer Res 32:1861-1863, 1972.
19. Wolff GL, Roberts DW, Morrissey RL, Greenman DL, Allen RR, Campbell WL, Bergman H, Nesnow S, Frith CH. Tumorigenic responses to lindane in mice: potentiation by a dominant mutation. Carcinogenesis 8:1889-1897, 1987.
20. Furumura M, Potterf SB, Toyofuku K, Matsunaga J, Muller J, Hearing VJ. Involvement of ITF2 in the transcriptional regulation of melanogenic genes. J Biol Chem 276:28147-28154, 2001.
21. Polakis P. Wnt signaling and cancer. Genes Dev 14:1837-1851, 2000.